About Index Trending news
Analyze
Top 50 Pricing
CEVEC Pharmaceuticals

CEVEC Pharmaceuticals

Work at CEVEC Pharmaceuticals? Add yourself to this profile

CEVEC Pharmaceuticals

CEVEC Pharmaceuticals develops therapeutic proteins and monoclonal antibodies with human glycosylation patterns.

Elsewhere

Alexa global traffic share

Latest funding
Venture capital
$8,628,000
Venture capital (Series B)
$5,400,000
Employees

Team size

10+

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when CEVEC Pharmaceuticals makes some noise.